SILVERCREST ASSET MANAGEMENT GROUP LLC

Position in LH — Labcorp Holdings Inc.

CIK 1232395 NEW YORK, NY

Position in LH

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$5,426,381

+$298,896 QoQ

Shares Held

20,338

-0.5% QoQ

Ownership

0.025%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

SILVERCREST ASSET MANAGEMENT GROUP LLC holds $175,895,059 across 15 Diagnostics & Research names. LH ranks #8 (3.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc.	90,091	$44,282,429
2	A	Agilent Technologies, Inc.	257,387	$29,336,970
3	DGX	Quest Diagnostics Inc	114,758	$22,490,272
4	RDNT	RadNet, Inc.	381,502	$21,322,146
5	DHR	Danaher Corp /De/	105,157	$19,937,767
6	TWST	Twist Bioscience Corp	244,025	$11,596,068
7	CSTL	Castle Biosciences Inc	268,535	$6,592,534
8	LH	Labcorp Holdings Inc. This page	20,338	$5,426,381

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,426,381	20,338	-0.5%	Shares	Sole	2026-05-15
2025-12-31	$5,127,485	20,438	0.0%	Shares	Sole	2026-02-17
2025-09-30	$5,866,932	20,438	-0.2%	Shares	Sole	2025-11-14
2025-06-30	$5,373,842	20,471	+0.3%	Shares	Sole	2025-08-14
2025-03-31	$4,752,318	20,419	-12.3%	Shares	Sole	2025-05-15
2024-12-31	$5,338,798	23,281	-0.9%	Shares	Sole	2025-02-14
2024-09-30	$5,250,886	23,496	-0.1%	Shares	Sole	2024-11-14
2024-06-30	$4,788,793	23,531	—	Shares	Sole	2024-08-15
No filing history on record for this holder in this stock.